| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Crinetics Pharmaceuticals, Inc. (CRNX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. CRNX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 426.8K | $15.99M | - | |
| Dir | 116.1K | $4.35M | - | |
| Other | 71.8K | $2.69M | - | |
| Other | 55.0K | $2.06M | - | |
| COO | 55.0K | $2.06M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28, 2024 | Wilson Marc53 | CFO | Sale+OE | 32,129 | $43.61 | $1,401,145.69 | -22.4% | +12.9% | -33.1% | |
| Jun 26, 2024 | Knight Jeff E.68 | Chief Operating Officer | Sell | 956 | $44.38 | $42,427.28 | -1.8% | +18.1% | -28.9% | |
| Jun 25, 2024 | Betz Stephen F.61 | Chief Scientific Officer | Sell | 3,000 | $45.37 | $136,110.00 | -3.6% | +12.4% | -32.2% | |
| Jun 24, 2024 | Pizzuti Dana56 | Chief Med And Dev Officer | Sale+OE | 9,500 | $45.73 | $434,435.00 | -25.5% | +10.4% | -32.2% | |
| Jun 21, 2024 | Hassard James61 | Chief Commercial Officer | Sale+OE | 15,000 | $44.66 | $669,900.00 | -33.9% | +18.2% | -33.8% | |
| Jun 10, 2024 | Betz Stephen F.61 | Chief Scientific Officer | Sell | 3,000 | $43.86 | $131,580.00 | -3.5% | +16.1% | -26.5% | |
| May 28, 2024 | Betz Stephen F.61 | Chief Scientific Officer | Sell | 3,000 | $47.49 | $142,470.00 | -3.3% | +13.4% | -36.2% | |
| May 10, 2024 | Betz Stephen F.61 | Chief Scientific Officer | Sell | 3,000 | $49.43 | $148,290.00 | -3.2% | +5.7% | -36.1% | |
| May 8, 2024 | Struthers Richard Scott54 | President &CEO | Sale+OE | 107,448 | $49.40 | $5,307,931.20 | -29.4% | -1.4% | -35.7% | |
| Apr 15, 2024 | Pizzuti Dana56 | Chief Med And Dev Officer | Sale+OE | 14,375 | $44.47 | $639,256.25 | -34.1% | +23.9% | -32.1% |